Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 13 | 2019 | 571 | 2.810 |
Why?
|
| Coronary Artery Disease | 3 | 2019 | 297 | 1.260 |
Why?
|
| Hospitalization | 2 | 2019 | 732 | 0.850 |
Why?
|
| Acute Kidney Injury | 3 | 2021 | 315 | 0.740 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 9 | 0.640 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 41 | 0.630 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2018 | 2 | 0.620 |
Why?
|
| Myeloblastin | 1 | 2018 | 4 | 0.620 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 8 | 0.610 |
Why?
|
| Glomerulonephritis | 1 | 2018 | 15 | 0.610 |
Why?
|
| Ontario | 5 | 2019 | 55 | 0.590 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 123 | 0.590 |
Why?
|
| Paraproteinemias | 1 | 2018 | 74 | 0.580 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 98 | 0.570 |
Why?
|
| Forecasting | 2 | 2018 | 154 | 0.570 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 413 | 0.550 |
Why?
|
| Risk Assessment | 2 | 2018 | 1323 | 0.480 |
Why?
|
| Stroke | 1 | 2019 | 509 | 0.430 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 486 | 0.420 |
Why?
|
| Troponin | 1 | 2013 | 14 | 0.410 |
Why?
|
| Myocardial Revascularization | 1 | 2013 | 21 | 0.410 |
Why?
|
| Patient Readmission | 3 | 2017 | 243 | 0.320 |
Why?
|
| Comorbidity | 3 | 2019 | 624 | 0.280 |
Why?
|
| Humans | 20 | 2021 | 52336 | 0.250 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 3391 | 0.250 |
Why?
|
| Diabetes Complications | 1 | 2007 | 123 | 0.250 |
Why?
|
| Kidney Diseases | 2 | 2019 | 220 | 0.250 |
Why?
|
| Aged | 7 | 2019 | 10109 | 0.250 |
Why?
|
| Prognosis | 3 | 2019 | 2094 | 0.240 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 443 | 0.230 |
Why?
|
| Male | 12 | 2020 | 26696 | 0.230 |
Why?
|
| Coronary Angiography | 2 | 2019 | 366 | 0.220 |
Why?
|
| Heart Diseases | 1 | 2007 | 222 | 0.220 |
Why?
|
| Risk Factors | 5 | 2021 | 3872 | 0.210 |
Why?
|
| Female | 11 | 2020 | 28105 | 0.180 |
Why?
|
| Middle Aged | 8 | 2020 | 13014 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 41 | 0.170 |
Why?
|
| Colitis | 1 | 2020 | 51 | 0.160 |
Why?
|
| Calcium Oxalate | 1 | 2019 | 8 | 0.160 |
Why?
|
| Hospital Mortality | 2 | 2019 | 428 | 0.160 |
Why?
|
| Tissue Fixation | 1 | 2019 | 36 | 0.160 |
Why?
|
| Syndrome | 2 | 2013 | 247 | 0.160 |
Why?
|
| Glomerular Mesangium | 1 | 2018 | 7 | 0.150 |
Why?
|
| Exercise Test | 2 | 2017 | 141 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 253 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 484 | 0.140 |
Why?
|
| Hospitals | 1 | 2019 | 181 | 0.140 |
Why?
|
| Diuretics | 1 | 2017 | 31 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2019 | 1532 | 0.140 |
Why?
|
| Needles | 1 | 2017 | 25 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 741 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2017 | 22 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2021 | 6578 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1676 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 182 | 0.130 |
Why?
|
| Kidney | 2 | 2021 | 708 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2019 | 706 | 0.130 |
Why?
|
| Prevalence | 1 | 2019 | 1007 | 0.130 |
Why?
|
| Recurrence | 1 | 2018 | 672 | 0.120 |
Why?
|
| Tricuspid Valve | 1 | 2016 | 25 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1021 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 870 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 49 | 0.120 |
Why?
|
| Heart Rate | 1 | 2017 | 319 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2014 | 6 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2016 | 164 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1162 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 659 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2014 | 153 | 0.110 |
Why?
|
| Cause of Death | 1 | 2013 | 160 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2013 | 68 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2268 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 288 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1543 | 0.100 |
Why?
|
| Propensity Score | 1 | 2013 | 155 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 78 | 0.090 |
Why?
|
| Acute Disease | 1 | 2013 | 374 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 920 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 521 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2016 | 1066 | 0.070 |
Why?
|
| Angina, Unstable | 1 | 2007 | 24 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 23 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2007 | 59 | 0.070 |
Why?
|
| Time Factors | 1 | 2013 | 2957 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 117 | 0.060 |
Why?
|
| Inflammation | 1 | 2007 | 642 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2013 | 5407 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2021 | 13 | 0.050 |
Why?
|
| Genotype | 1 | 2021 | 569 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 108 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 85 | 0.040 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2017 | 3 | 0.040 |
Why?
|
| Furosemide | 1 | 2017 | 13 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2017 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 985 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 604 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1044 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 150 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2017 | 82 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 238 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 26 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 192 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2016 | 268 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 401 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 719 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 590 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1201 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 14139 | 0.020 |
Why?
|